Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBT Margin: 2010-2012

Historic EBT Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -26.95%.

  • Sonoma Pharmaceuticals' EBT Margin rose 6671.00% to -26.95% in Q4 2012 from the same period last year, while for Dec 2012 it was -29.58%, marking a year-over-year increase of 2979.00%. This contributed to the annual value of -58.02% for FY2012, which is 2305.00% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' EBT Margin stood at -26.95%, which was down 11.29% from -24.22% recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' EBT Margin ranged from a high of -19.30% in Q2 2012 and a low of -108.44% during Q2 2010.
  • For the 3-year period, Sonoma Pharmaceuticals' EBT Margin averaged around -58.50%, with its median value being -56.66% (2011).
  • Examining YoY changes over the last 5 years, Sonoma Pharmaceuticals' EBT Margin showed a top increase of 6,671bps in 2012 and a maximum decrease of 76bps in 2012.
  • Quarterly analysis of 3 years shows Sonoma Pharmaceuticals' EBT Margin stood at -94.47% in 2010, then spiked by 81bps to -93.66% in 2011, then surged by 6,671bps to -26.95% in 2012.
  • Its EBT Margin was -26.95% in Q4 2012, compared to -24.22% in Q3 2012 and -19.30% in Q2 2012.